Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
On semaglutide, nausea can be pronounced, especially in the first 12 months
Diabetes, Obesity Metab
10.1016/j.arcmed.2008.06.005 34
CrossRef From pathophysiology to therapy: molecular mechanisms of stem cell and extracellular vesicle-mediated repair in diabetic peripheral neuropathy Jiayi Zhou, Yang Yu, Liuchang Song, Peipei Qian, Mengni Zhao, Fei Ding, Xuegan Lian, Miaomei Yu Frontiers in Cell and Developmental Biology.2026;[Epub] CrossRef Quality of life in older adults with diabetic peripheral neuropathy: International Classification of Functioning, Disability and Health (ICF) framework Oktaviani Fitriyah, Dwi Rosella Komalasari, Umi Budi Rahayu Fisioterapia em Movimento.2026;[Epub] CrossRef Mechanistic Insights into Diabetic Neuropathy: Oxidative Stress, Mitochondrial Injury, and Translational Therapeutics Muzafar Ahmad Mir, Showkat ul Nabi, Rakeeb Ahmad Mir, Sofi Imtiyaz Ali, Irfan Ahmed Noorani, Shabista Muzaffar, Ibraq Khurshid SN Comprehensive Clinical Medicine.2026;[Epub] CrossRef The role of brain mechanisms in diabetic peripheral neuropathy: recent advances and comprehensive analysis Min Wei, Ye Jiang, Jiayin Shou, Guogang Xing, Min Li Frontiers in Cellular Neuroscience.2025;[Epub] CrossRef On a Phenotypic Approach to Diabetic Peripheral Neuropathy (Diabetes Metab J 2025;49:542-64) Antonio Alcntara Montero Diabetes & Metabolism Journal.2025
Purpose-built for physicians GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes Key takeaways: People with type 2 diabetes using a GLP-1 medication have a lower risk for most obesity-associated cancers than insulin users
